Vimentin, colon cancer progression and resistance to butyrate and other HDACis - Wikidata - awgldk - TriplyDB

Vimentin, colon cancer progression and resistance to butyrate and other HDACis

Vimentin, colon cancer progression and resistance to butyrate and other HDACis

http://www.wikidata.org/entity/Q26748816

about

LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1 Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients.Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner.Butyrate Inhibits Cancerous HCT116 Colon Cell Proliferation but to a Lesser Extent in Noncancerous NCM460 Colon Cells.Role of ARPC2 in Human Gastric Cancer.Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer.Upregulation of NETO2 gene in colorectal cancer.Epithelial-mesenchymal transition, and collective and individual cell migration regulate epithelial changes in the amikacin-damaged organ of Corti.Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance.Oncogenic role of PDK4 in human colon cancer cells.Hypothesis: Cancer Is a Disease of Evolved Trade-Offs Between Neoplastic Virulence and Transmission.Vimentin Diversity in Health and Disease Colorectal carcinogenesis: Insights into the cell death and signal transduction pathways: A review

P2860

Q28468512-DCF8752B-B991-4491-9923-78C0A221E2BF Q33821532-EB6BFBD3-8EF7-4F02-9649-FC76DDEDD97A Q36320084-FC447D2D-956F-497C-BBE0-C0B2B39EA8CF Q37628348-CDDE278A-AD76-4058-AB19-23B4F71339F4 Q38697602-64602219-856E-4B7F-9A7F-DCD1847AE161 Q38721483-2D78F8A8-697E-4915-B13E-A2FD31B2279B Q47113925-7B3180E1-6196-4AB5-A5CC-A1F0FAF56A7C Q48339195-8EFDAB14-7CF0-4977-9AE9-8D3AF8F21560 Q49205960-047739D1-BC4D-4676-8F76-568B2F8FE47D Q51135000-F9677CF7-EBB4-42F8-96A8-C72301C0C998 Q55384150-4DB2E67B-6F7A-4EB2-929B-D57FCF5C8D47 Q58702541-83AB8BAD-91D3-46F3-90D7-7E85E7D2AD0D Q58737393-0895BE67-E76F-4E97-8764-79041ADD6A1E

P2860

Vimentin, colon cancer progression and resistance to butyrate and other HDACis

http://www.wikidata.org/entity/Q26748816

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Vimentin, colon cancer progression and resistance to butyrate and other HDACis

@ast

Vimentin, colon cancer progression and resistance to butyrate and other HDACis

@en

Vimentin, colon cancer progression and resistance to butyrate and other HDACis

@nl

type

label

Vimentin, colon cancer progression and resistance to butyrate and other HDACis

@ast

Vimentin, colon cancer progression and resistance to butyrate and other HDACis

@en

Vimentin, colon cancer progression and resistance to butyrate and other HDACis

@nl

prefLabel

Vimentin, colon cancer progression and resistance to butyrate and other HDACis

@ast

Vimentin, colon cancer progression and resistance to butyrate and other HDACis

@en

Vimentin, colon cancer progression and resistance to butyrate and other HDACis

@nl

P1433

Q26748816-4FEC62B7-994F-4E57-AA90-659C79BE22C0

P1476

Q26748816-C30BCDC5-CF70-4452-BE1D-B97DD19EBF27

P2093

Q26748816-E022C5E2-BBC5-44A5-8C54-1A7D5D8FF24B

Q26748816-F803ED66-4203-4EFA-808D-F0611FBCC84F

P275

Q26748816-0FFF6508-D24F-4DED-8BEE-C8ED2C733FF9

P2860

Q26748816-064683C6-4B78-4DF5-AD82-1A0EA1757DEA

Q26748816-0C57C623-CBDF-4861-B36A-7ACFC1B35DD8

Q26748816-0E0E225C-40A0-4128-815B-E8E7620AE64D

Q26748816-11D32DDD-BC59-4241-88B4-CE4DEE850EE9

Q26748816-136F4C64-CC6E-4D5A-8412-FE981D44C34E

Q26748816-14C28ADB-E834-48C9-8C80-270D4447392C

Q26748816-1516F68F-8726-41FA-9869-7E3047C896C6

Q26748816-1762C9E9-2EC9-4974-BA7B-F2F9125C6B86

Q26748816-1C6ACDBE-E761-4DFD-9F6E-BED57D0795E6

Q26748816-213BD18F-6CA4-4917-B8CD-AEE704582829

P304

Q26748816-230E34E1-8F7F-45C0-8275-39D8BF696A07

P31

Q26748816-1E2B04C6-9BA6-4574-AF3F-42489A74EE43

Q26748816-CE18BDE1-1883-4113-B15E-B4375CC52FC4

P3181

Q26748816-79BDD263-D360-4F68-9AB4-5A7C9083054A

P356

Q26748816-F0E5097C-80E2-4D2B-AE15-D74229E51760

P407

Q26748816-510E1A05-A7EE-4578-A4C4-74665AAE25E5

P433

Q26748816-DED69DE7-C60F-40D8-A19F-E21481558CA7

P478

Q26748816-E6C178A8-7D96-4368-8DB1-BED4D9264FF9

P5008

Q26748816-D59DDFBE-B820-4742-AD6F-D92A64089523

P577

Q26748816-7F98B9A4-CCA3-4F75-9351-601C2B9DB614

Q26748816-B10DD964-6F80-44BD-98D0-B169B863F0F1

P698

Q26748816-A3286685-CEBB-4E92-B29E-B9D584059058

P921

Q26748816-182e9acc-49aa-f6d7-d674-e1087aebcede

Q26748816-7d92540d-49f6-b098-3698-8a12ded69299

Q26748816-88811DC6-4017-4BEB-8173-88911092DC4E

Q26748816-a8b455b7-4aae-347c-df6b-ba427b2ce1ae

Q26748816-ae932d8f-406b-04a8-3c11-896ad3c0dd23

Q26748816-df1a8e89-4c8b-2ee2-b670-511e86cdb855

P932

Q26748816-0EDCB8B8-D298-44EC-B1E1-4EAB783E4705

P3181

P356

P1433

Journal of Cellular and Molecular Medicine

P1476

Vimentin, colon cancer progression and resistance to butyrate and other HDACis

@en

P2093

Darina L Lazarova

http://www.w3.org/2001/XMLSchema#string

Michael Bordonaro

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex

The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin

Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study

Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies

A switch from canonical to noncanonical Wnt signaling mediates drug resistance in colon cancer cells

Withaferin a alters intermediate filament organization, cell shape and behavior

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma.

P304

989-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4904129

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/JCMM.12850

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27072512

http://www.w3.org/2001/XMLSchema#string

P921

antineoplastic resistance

colonic neoplasm

histone deacetylase inhibitors

disease progression

P932

4882977

http://www.w3.org/2001/XMLSchema#string